1Wolnicka-Glubisz A, Noonan F: Expression of the stem cell markers Sca-1, CD34, CD45 and c-kit in neonatal mouse skin. J Invest Dermatol 123:172, A29, 2004 (abstr).
SCA-1+ Cells with an Adipocyte Phenotype in Neonatal Mouse Skin
Version of Record online: 28 JUN 2008
Journal of General Internal Medicine
Volume 20, Issue 5, pages 383–385, May 2005
How to Cite
Wolnicka-Glubisz, A., King, W. and Noonan, F. P. (2005), SCA-1+ Cells with an Adipocyte Phenotype in Neonatal Mouse Skin. Journal of General Internal Medicine, 20: 383–385. doi: 10.1111/j.0022-202X.2005.23781.x
- Issue online: 28 JUN 2008
- Version of Record online: 28 JUN 2008
- Manuscript received November 1, 2004; revised February 7, 2005; accepted for publication March 3, 2005
fatty-acid binding protein 4;
stem cell antigen-1
To The Editor:
There is considerable current interest in stem cells, not only in order to understand the processes of development, regeneration, and carcinogenesis but also because readily accessible tissues such as the skin may be an excellent resource of autologous stem cells to treat human disease (Baksh et al, 2004). Cells that mature into functionally different lineages have been described in the skin (Taylor et al, 2000; Albert et al, 2001; Potten and Booth, 2002; Jahoda et al, 2003; Trempus et al, 2003; Dyce et al, 2004). For example, skin-derived precursor cells have been described that can differentiate into neurons, muscle, and adipocytes (Toma et al, 2001). With the exception of keratinocyte and melanocyte stem cells, the origin and characteristics of skin stem cells are, however, not well defined.
Stem cell antigen-1 (Sca-1; Ly-6A/E) is a well-established marker for bone marrow-derived murine stem cell enrichment for both hematopoietic and mesenchymal stem cells (Patterson et al, 2000; Baddoo et al, 2003; Bonyadi et al, 2003) but has been little investigated in skin. We have identified in neonatal mouse skin a major population of Sca-1+ cells that do not express c-kit or CD45 but that express adipocyte markers. A preliminary report of this study has been made.1
Sca-1 visualized by immunohistochemistry in neonatal skin showed positive staining cells in the lower dermis, in the sebaceous glands, and in the panniculus adiposus of the hypodermis (Fig 1A, C; for methods, see Supplementary data and Table S1). It was unexpected to find such a large population of Sca-1+ cells in the skin, since in the bone marrow, less than 1% of cells are positive for Sca-1. Double staining with antibodies to the stem cell marker CD34 indicated the Sca-1+ cells in the lower dermis and sebaceous glands were mostly negative for CD34, whereas Sca-1+CD34+ cells positive for both markers were readily identifiable in the panniculus adiposus (Fig 1A). Further, CD34+ cells that did not express Sca-1 were found chiefly in the upper dermis (Fig 1A). Since adipocytes are a major component of the lower dermis and the panniculus adiposus, skin sections were stained with red oil that visualizes fat and also with an adipocyte-specific antibody to fatty-acid binding protein 4 (FABP4, Ap2) (Fruhbeck et al, 2001) (Fig 1B, D). Red oil staining, indicating the presence of fat, was readily observed in the lower dermis and in the sebaceous glands, corresponding to the localization of Sca-1+CD34− cells (Fig 1D). Interestingly, the panniculus adiposus, the major source of Sca-1+CD34+ cells, did not stain with red oil, suggesting that these cells may be immature cells of the adipocyte lineage since, in development (Hausman et al, 1981), adipocyte precursors progress from the hypodermis to the dermis. Positive staining for FABP4 observed in the lower dermis and in the hypodermis, although not in sebocytes, supported this contention (Fig 1B). Double staining of frozen sections with antibodies to Sca-1 and to 6-α integrin revealed rare double-positive cells (Fig S5A).
To further characterize Sca-1+ cells, single-cell suspensions were prepared from neonatal mouse skin (for methods, see Supplementary data and Table S1) and examined by FACS analysis for surface expression of the stem cell markers Sca-1, CD34, and c-kit (Fig 2A and Fig S1). Major populations of Sca-1+ cells and of CD34+ cells and of double-positive Sca-1+CD34+ cells were readily identified (Fig 2A, upper panel and Fig S1, upper row), consistent with the immunohistochemistry data. Double staining indicated that all Sca-1+ cells and all CD34+ cells were negative for c-kit (Fig 2A, middle and lower panels and Fig S1, middle and lower rows). The percentages of Sca-1+ and CD34+ cells decreased significantly with age, whereas the percentage of c-kit+ cells was constant over the same time period (Fig S2). The decrease in Sca-1+ cells as a percentage of total cells from postnatal days 1 to 5, even though the percentage of c-kit cells remained constant, argued in favor of a role for Sca-1+ cells in early postnatal development.
Double staining for Sca-1 and CD34 confirmed three subpopulations (Fig 2A, upper panel and Fig S1, upper row)—a double-positive Sca-1+CD34+ population (8%–10% of total) that was actively cycling (7.2% of cells in G2/M phase; Fig S3), a single positive Sca-1+CD34− (15%–20% of total), quiescent population (1.7% of cells in G2/M phase; Fig S3), and a Sca-1 negative population of CD34+ cells (3%–4% of total). Similar results were found by FACS analysis using two different commercially available anti-Sca-1 monoclonal antibodies (Table S1). Mast cells were readily identifiable by toluidine blue staining in the c-kit+Sca-1− population but not in the c-kit−Sca-1+ population (Fig S4), in contrast to previous publications that adult peritoneal and bone marrow mast cells carry Sca-1 (Drew et al, 2002). Double staining for Sca-1 and for 6-α integrin further revealed a subpopulation of double positive cells (Fig S6), again consistent with the immunohistochemistry data.
Cytospin preparations of sorted Sca-1+CD34+ and Sca-1+CD34− populations were stained with antibodies to the adipose-specific marker FABP4, to keratin 14, and to CD45, a lineage marker for hemopoietic cells. Both Sca-1+ populations showed positive staining for FABP4 (Fig 2B, upper two panels) but were negative for keratin and for CD45 (Fig 2B, middle and lower panels), again consistent with an adipose phenotype. In contrast, Sca-1−CD34+ and Sca-1−CD34− cells were negative for FABP4 (data not shown). 6-α integrin-positive cells were sorted and cytospins were double stained for Sca-1 and for keratin 14. Single positive cells were readily identified with each antibody but no double-stained cells, indicating that Sca-1+ 6-α integrin+ cells did not express keratin 14 (Fig S5B).
In conclusion, we have demonstrated that neonatal mouse dermis and hypodermis contain Sca-1+ cells that do not express the hemopoietic stem cell marker c-kit, the lineage marker CD45, or keratin 14 but that do express the adipocyte marker FABP4. A role for Sca-1 in adipocyte development is supported by the observation that Ly-6A/E (Sca-1) null mice (Bonyadi et al, 2003) exhibited, in addition to long-term defects in osteoprogenitors, a deficiency in adipocyte colony-forming cells. Further, a CD34+ stem cell that could differentiate into adipocytes was identified from human adipose stromal tissue (Gronthos et al, 2001). In this regard, a recent report2 identified Sca-1+CD34+ dermal cells from neonatal mouse skin that matured into adipocytes or sebocytes on culture. The plasticity of the Sca-1+ cells we have identified and whether they can give rise to cells of other lineages as described for Sca-1+c-kit− skin-derived precursor cells located in the dermal papillae (Fernandes et al, 2004) or whether they are fully committed to the adipocyte lineage is of considerable interest.
2Meidl S, Elbe-Burger A: The murine dermis contains cells with in vitro clonogenic potential. J Invest Dermatol 123:051, A9, 2004 (abstr).
We thank Drs Nancy Noben-Trauth and Hisashi Nagase for assistance with skin disaggregation, Drs Stephanie Constant, Sally Moody, and Ms Himani Majumdar for use of equipment, and Dr Robyn Rufner for assistance with microscopy. This work was supported by NIH CA 92258.
The following supplementary material is available for this article online.
Supplemental Text Materials and Methods
- Murine epidermal label-retaining cells isolated by flow cytometry do not express the stem cell markers CD34, Sca-1, or Flk-1. J Invest Dermatol 117: 943–948, 2001 , , :
- Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 89: 1235–1249, 2003 , , , , , , :
- Adult mesenchymal stem cells: Characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8: 301–316, 2004 , , :
- Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci USA 100: 5840–5845, 2003 , , , , , :
- CD34 is a specific marker of mature murine mast cells. Exp Hematol 30: 1211–1218, 2002 , , , , :
- Stem cells with multilineage potential derived from porcine skin. Biochem Biophys Res Commun 316: 651–658, 2004 , , , :
- A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 6: 1082–1093, 2004 , , , et al:
- The adipocyte: A model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 280: E827–E847, 2001 , , , :
- Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189: 54–63, 2001 , , , , , :
- Adipocyte development in the rat hypodermis. Am J Anat 161: 85–100, 1981 , , , :
- Hair follicle dermal cells differentiate into adipogenic and osteogenic lineages. Exp Dermatol 12: 849–859, 2003 , , , :
- Characterization of Ly-6M, a novel member of the Ly-6 family of hematopoietic proteins. Blood 95: 3125–3132, 2000 , , , :
- Keratinocyte stem cells: A commentary. J Invest Dermatol 119: 888–899, 2002 , :
- Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 102: 451–461, 2000 , , , , :
- Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3: 778–784, 2001 , , , , , , :
- Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34. J Invest Dermatol 120: 501–511, 2003 , , , , , , :